Global Point-of- Care Coagulation Testing Devices Market, By Device Type (Anticoagulation Monitoring Devices, Platelet Function Monitoring Devices, Viscoelastic Function Monitoring Devices and Other Monitoring Devices), End User (Hospitals and Clinics, Home Care and Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2029.
Market Analysis and Insights Global Point-of-Care Coagulation Testing Devices Market
Data Bridge Market Research analyses that the point-of-care coagulation testing devices market is growing at a CAGR of 5.21% in the forecast period of 2022-2029 and is likely to reach USD 1,331.254 million in 2029.
Fast and specific testing of bodily liquids at the bedside is called Point-of-care testing (POCT). Conventional laboratory tests usually have a long turnaround time.
The increasing number of bleeding disorders cases around the globe is the major factor accelerating the growth of the point-of-care coagulation testing devices market. Furthermore, Covid-19, rising preference of home treatment and usage of POCCT devices in the ICUs for rapid results are also expected to drive the growth of the point-of-care coagulation testing devices market. However, the high cost of these POCCT testing devices and need of professionals to use POCCT devices restrains the point-of-care coagulation testing devices market, whereas, several researches have declared the test results at the central laboratories to be more reliable than the tests by the POCCT devices will challenge market growth.
In addition, increasing trend of home care services and self-monitoring will create ample opportunities for the point-of-care coagulation testing devices market.
This point-of-care coagulation testing devices market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on point-of-care coagulation testing devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Point-of- Care Coagulation Testing Devices Market Scope and Market Size
The point-of-care coagulation testing devices market is segmented on the basis of device type & end-user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of device type, the point-of-care coagulation testing devices market is segmented into anticoagulation monitoring devices, platelet function monitoring devices, viscoelastic function monitoring devices and other monitoring devices.
- On the basis of end-user, the point-of-care coagulation testing devices market is segmented into hospitals and clinics, home care and others.
Point-of- Care Coagulation Testing Devices Market Country Level Analysis
The point-of-care coagulation testing devices market is segmented on the basis of device type & end-user.
The countries covered in the point-of-care coagulation testing devices market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the point-of-care coagulation testing devices market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to an increasing number of bleeding disorders among the population in this region. Asia-Pacific on the other hand is projected to exhibit the highest growth rate during the forecast period due to the high healthcare expenditure and technology advancement in this region.
The country section of the point-of-care coagulation testing devices market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The point-of-care coagulation testing devices market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for point-of-care coagulation testing devices market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the point-of-care coagulation testing devices market. The data is available for historic period 2010 to 2020.
Competitive Landscape and Point-of-Care Coagulation Testing Devices Market Share Analysis
The point-of-care coagulation testing devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to point-of-care coagulation testing devices market.
Some of the major players operating in the point-of-care coagulation testing devices market report are F. Hoffmann-La Roche Ltd, Siemens AG, Beckman Coulter, Inc., BD, Johnson & Johnson Services, Inc., Instrumentation Laboratory, PTS Diagnostics, Abaxis, Medtronic, Accriva Diagnostics, Opti Medical, Sienco, Inc., Alpha Scientific Electronics, AccuBioTech Co., Ltd., ACON Laboratories, Inc., Acrongenomics Inc., bioMérieux SA, Biomerica, Inc., Binx Health, Inc., Alfa Scientific Designs, Inc., Bio-Rad Laboratories, Inc., Medica Corporation, Nova Biomedical among other
SKU-